### **Investors Alert: Class Action Lawsuit Against Reckitt Benckiser Group PLC**
**Are you an investor in Reckitt Benckiser Group PLC (OTC: RBGLY)?** You may have a significant opportunity at hand as the **Rosen Law Firm** announces the filing of a class action lawsuit on behalf of purchasers of American Depositary Shares (ADSs) during the period from **January 13, 2023, to July 28, 2024**.
### **Important Dates and Next Steps**
If you purchased Reckitt’s ADSs during this time frame, it’s crucial to act swiftly. The **deadline to move the Court as a lead plaintiff is August 4, 2025**. Leading the class action lawsuit allows you to represent fellow investors and guide the litigation process.
For those wishing to take part in this class action, **you can join by visiting** [Rosen Law Firm’s submission form](https://rosenlegal.com/submit-form/?case_id=40120) or contacting **Phillip Kim, Esq.** at **866-767-3653**. You can also reach out via email at **[email protected]** for further information.
### **Compensation Opportunities Without Out-of-Pocket Costs**
What does this mean for you? If you qualify, you may be entitled to **compensation without any personal financial burden**, thanks to a contingency fee agreement. This means you can pursue justice while minimizing your financial risk.
### **Why Choose Rosen Law Firm?**
**The Rosen Law Firm** is renowned for its track record in securities class actions. Here’s why you should consider them:
– **Successful Settlements**: The firm achieved the largest securities class action settlement against a Chinese company at its time.
– **Ranked Top**: They have been consistently recognized for the number of settlements and have secured **over $438 million for investors in 2019 alone**.
– **Expert Leadership**: With accolades including being ranked as a Titan of Plaintiffs’ Bar by Law360, the firm stands out in legal expertise and experience.
### **Understanding the Case Details**
The lawsuit alleges that during the class period, Reckitt Benckiser Group failed to adequately inform investors and consumers about critical health risks associated with its product, **Enfamil**. Key issues include:
1. **Increased Risk**: It was reported that preterm infants faced heightened risks of developing **necrotizing enterocolitis (NEC)** from Reckitt’s cow’s milk-based formula.
2. **Sales Impact**: The lawsuit claims that Reckitt misrepresented the implications for sales due to potential legal claims.
3. **Misleading Statements**: Positive public statements about Reckitt’s business and future prospects were allegedly misleading and lacked factual backing.
The suit asserts that when these facts became public, **investors experienced significant losses** as a result.
### **Join the Action and Stay Informed**
To become part of the Reckitt Benckiser class action:
– Fill out the form on [Rosen Law’s website](https://rosenlegal.com/submit-form/?case_id=40120)
– Or contact **Phillip Kim, Esq.** at **866-767-3653** or via email at **[email protected]**.
Keep in mind that no class has been certified yet. You do not have representation unless you choose to be represented by a counsel of your choice. However, your potential to benefit from any future recovery does not hinge on acting as lead plaintiff.
### **Stay Updated with Rosen Law Firm**
For real-time updates and further information, follow the **Rosen Law Firm** on social media:
– [LinkedIn](https://www.linkedin.com/company/the-rosen-law-firm)
– [Twitter](https://twitter.com/rosen_firm)
– [Facebook](https://www.facebook.com/rosenlawfirm)
### **Contact Information**
For immediate assistance, reach out to:
– **Laurence Rosen, Esq.**
– **Phillip Kim, Esq.**
– **The Rosen Law Firm, P.A.**
– **275 Madison Avenue, 40th Floor, New York, NY 10016**
– **Tel: (212) 686-1060**
– **Toll-Free: (866) 767-3653**
– **Fax: (212) 202-3827**
– **Email: [email protected]**
**Remember**, prior results do not guarantee a similar outcome. Be proactive and protect your rights as an investor.
